BioWorld Science

Sep. 12, 2012

View Archived Issues

AEterna Zentaris presents promising in vivo data for AEZS-136

Read More

SQ-609: a dipiperidine for tuberculosis

Read More

SNS01-T combined with bortezomib effective in mouse tumor model

Read More

New bimatoprost prodrugs prepared at Allergan

Read More

Santaris Pharma discloses new oligonucleotides

Read More

Last patient completes treatment in phase IIb bremelanotide trial

Read More

AB-103 receives fast track designation from FDA

Read More

U.S. team presents novel chimeric antibodies for poliovirus infection

Read More

Zalicus reports topline phase IIb results for Synavive in rheumatoid arthritis

Read More

Pro Bono Bio obtains exclusive license to TheraPEG technology

Read More

Transgene Biotek patents novel fusion proteins for HIV

Read More

Sanofi presents novel PI3K-beta inhibitor with activity in PTEN-deficient tumors

Read More

Bristol-Myers licenses Summit's Seglin drug discovery platform

Read More

Novel antirheumatic drug iguratimod launched in Japan

Read More

Radiolabeled TSPO shows potential as a new imaging biomarker of NAFLD

Read More

Patient dosing begins in phase I/II trial of Pergamum's therapeutic peptide for hard-to-heal wounds

Read More

First launch of Pixuvri carried out in European countries

Read More

Arsanis receives additional grants for anti-infective monoclonal antibody programs

Read More

Eaton Scientific to develop non-hormonal transdermal patch for hot flashes

Read More

FDA cites manufacturing deficiencies in Navidea's Lymphoseek NDA

Read More

MedImmune and WuXi AppTec to develop novel biologic for Chinese market

Read More

Critical Outcome Technologies takes steps toward IND filing of oral formulation

Read More

Researchers from Peregrine present topline results from a phase II study in NSCLC

Read More

Japanese MHLW grants priority review to Bayer's regorafenib NDA for colorectal cancer

Read More